Navigation Links
Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
Date:5/1/2009

EMERYVILLE, Calif., May 1 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII), today announced it has received a quarterly royalty payment of approximately $1.5 million from Merz Pharmaceuticals GmbH (Merz) for sales of Memantine for the treatment of Alzheimer's disease. Under an exclusive marketing agreement, NTI currently receives quarterly royalty payments on certain sales of Memantine by Merz and its marketing partners.

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. is a biopharmaceutical company historically focused on developing investigational drugs for central nervous system conditions. The company recently terminated development of its most advanced product candidate, Viprinex(TM) (ancrod), which was studied in Phase 3 clinical trials as a potential new drug to treat acute ischemic stroke. NTI has more recently chosen not to extend its early-stage research programs for Huntington's and Alzheimer's diseases. NTI has rights to receive payments from an approved drug for Alzheimer's disease and an investigational drug which has recently completed a Phase 3 trial for brain swelling.

www.ntii.com


'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
2. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
3. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
4. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
5. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
6. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
11. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)...  Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) ... criteria for the NASDAQ Global Select Market and effective ... the NYSE MKT. The company will continue to trade ... NASDAQ Global Select Market, a segment of the NASDAQ ... any exchange in the world, requiring that strict financial, ...
(Date:9/15/2014)... Sept. 15, 2014  The Female Health Company (NASDAQ-CM: ... join the Company,s management team as Executive Vice President ... also announced that Michael Pope will retire ... Operations, effective September 15, 2014.  Following his retirement, Mr. ... a Consultant. Prior to joining The Female ...
(Date:9/15/2014)... 2014 ResMed today announced that its AirView ... connected to Fairview Health Services, Epic EHR system, enabling ... for use by Fairview,s medical staff. Launched in June ... reduced cost, improved quality and responsiveness of therapy, and ... decision support. Sleep apnea occurs when ...
Breaking Medicine Technology:Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 3The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 2The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 3ResMed and Fairview Health Services Introduce Integration of Sleep and Respiratory Therapy Data into EHR System 2ResMed and Fairview Health Services Introduce Integration of Sleep and Respiratory Therapy Data into EHR System 3ResMed and Fairview Health Services Introduce Integration of Sleep and Respiratory Therapy Data into EHR System 4
... STATEN ISLAND, N.Y., Feb. 28, 2011  A 67-year-old man ... his wife after wandering outside in near-freezing temperatures thanks to ... a watch-like EmSeeQ® wearable locator device. ... Marilyn, discovered him missing. He was located on Victory Boulevard, ...
... Corporation (Nasdaq: HSKA ; "Heska" or the ... Thursday, March 3rd, 2011.  The company,s presentation is scheduled ... Mountain Time) and is to be available to interested ... is to be available via live webcast and for ...
Cached Medicine Technology:Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 2Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 3Heska to Present Live, Online at RetailInvestorConferences.com 2
(Date:9/15/2014)... The White House has recently begun ... in jail and prison and toward helping them access ... a positive change. , The nation is currently grappling ... According to an article from The Washington Post ... shift away from using the criminal justice system to ...
(Date:9/15/2014)... Maureen Salamon HealthDay Reporter ... Pediatricians prescribe antibiotics about twice as often as they,re ... a new study indicates. More than 11 million ... may be unnecessary, according to researchers from University of ... not only fails to eradicate children,s viral illnesses, researchers ...
(Date:9/15/2014)... that certain brain regions are associated with specific ... , How and where these specific abilities are ... is still under investigation. However, researchers at the ... Louis, Missouri, believe that several hub regions may ... as an integrated network. , In research published ...
(Date:9/15/2014)... Providing additional expertise to its ... (“the Firm”) is proud to welcome ... the Firm’s Litigation Support Services practice. ... Wolf will assist clients in litigation support, dispute ... matters. He will also provide guidance in the ...
(Date:9/15/2014)... MONDAY, Sept. 15, 2014 (HealthDay News) -- People who,ve had ... even one of nine critical steps in their treatment is ... the United Kingdom noted patients who missed a part of ... of developing symptoms, were more likely to miss other steps ... outcomes among heart attack patients can be improved if all ...
Breaking Medicine News(10 mins):Health News:White House Shifts Policy on Drugs 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Network measures predict neuropsychological outcome after brain injury 2Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 2Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 3Health News:Heart Attack Patients Face Greater Death Risk if Any Treatment Step Missed: Study 2
... Pack Increase Would Help Raise $390 Million, Save ... should,fund a proposed economic stimulus plan by increasing ... recommends a report released,today by the Campaign for ... tax alternative would reduce smoking, save lives and,save ...
... Corporation,(NYSE: STE ) today announced that its Board ... amount of $0.06 per common share. The,dividend is payable ... close of,business on May 14, 2008., About STERIS, ... a healthier today and,safer tomorrow through knowledgeable people and ...
... Mass.The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), a world ... it will award five grants totaling $1 million to ... vaccine. , Shan Lu, MD, PhD, professor of ... and colleague Katherine Ruiz De Luzuriaga, MD, professor of ...
... I Lost It at the Club!, a,fitness industry ... Health, Racquet & Sportsclub Association (IHRSA) and,sponsored by Michael ... members lose 28,101 inches and more than 45 tons,(90,068 ... Lost It at,the Club!, which ran for eight weeks ...
... Center at the University of North Carolina at Chapel Hill ... a key step in tumor progression. , This step ... to grow out of control and ultimately spread cancer to ... formation, or angiogenesis, promises to be less toxic than the ...
... prevents inflammation, hints of new treatments for disease , , ... may have discovered how tumors develop in the stomach, ... gastric cancer. , In a study done on mice, ... Institute for Cancer Research (LICR) found that blocking the ...
Cached Medicine News:Health News:New Report: Increasing Ohio's Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program 2Health News:New Report: Increasing Ohio's Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program 3Health News:New Report: Increasing Ohio's Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program 4Health News:STERIS Corporation Declares Regular Quarterly Dividend 2Health News:STERIS Corporation Declares Regular Quarterly Dividend 3Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 2Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 3Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 2Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 3Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 4Health News:Researchers identify new cell targets for preventing growth of breast and other tumors 2Health News:Researchers identify new cell targets for preventing growth of breast and other tumors 3Health News:Scientists Discover How Stomach Tumors Form 2
... EX accelerators are true ... Varian multileaf collimation and ... which enable you to ... computer-driven IMRT treatments, as ...
The Clinac 2100 C/D family of accelerators are reliable, easy-to-use, flexible and cost-effective systems....
The Clinac 6EX accelerator is a cost-effective choice. Configured for the latest treatment techniques, the Clinac 6EX has the tightest mechanical and dosimetric specifications for any single-energy m...
Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y...
Medicine Products: